Ozanimod vs. IFN bèta-1a in fase III-studie

Delen via:
ECTRIMS 2017

Log hier in om volledige toegang te krijgen.

Login of Account maken

 

Bronnen:
Cohen JA, Comi G, Selmaj KW, et al. Ozanimod vs interferon β-1a: clinical and MRI results of RADIANCE part B - A 2-year Phase 3 trial in relapsing multiple sclerosis. ECTRIMS 2017, 280.